Omika Health utilizes DNA sequencing technology and AI-driven analysis to provide early screening for DNA-associated diseases through home DNA-testing kits. This proactive approach addresses the issue of undiagnosed conditions, enabling personalized health insights and timely medical referrals for treatable conditions.
Funding
Funding not disclosed
Founders
Product
Problem
Millions of individuals go undiagnosed each year, leading to preventable deaths and illnesses because modern healthcare systems often focus on reactive treatment rather than proactive screening. Early detection of DNA-associated diseases is hindered by a lack of accessible and convenient screening methods.
Solution
Omika Health offers a preventive healthcare service that leverages DNA sequencing technology and AI-driven analysis to provide early screening for DNA-associated diseases. Members receive easy-to-use home DNA-screening kits, and Omika's ISO-certified laboratories extract and sequence DNA from blood samples using state-of-the-art technology. Advanced software filters genetic mutations, cross-references them with scientific literature, and identifies potential diseases. If harmful but treatable conditions are identified, Omika's doctors evaluate the case, conduct video consultations, and prepare referrals for primary healthcare providers, ensuring members receive appropriate care and treatment.
Target Audience
Individuals seeking proactive and personalized healthcare solutions, particularly those interested in early screening for DNA-associated diseases.
Features
- Home DNA-screening kits for convenient sample collection
- ISO-certified laboratories in Germany and Netherlands for DNA extraction and sequencing
- Advanced software that filters genetic mutations and cross-references them with scientific literature
- AI-driven analysis to identify potential diseases
- Personalized lifestyle advice for conditions treatable through lifestyle changes
- Doctor consultations and referrals to primary healthcare specialists for conditions requiring medical treatment
- Quarterly re-analysis of genetic data to incorporate the latest clinically validated findings
- Omika Home application to view genetic predispositions